Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/snail signaling

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2401-2408

  Zhang, Jiaxing ^a   Wei, Jinhuan ^a   Lu, Jian ^a   Tong, Zhuting ^b   Liao, Bing ^a   Yu, Bin ^c   Zheng, Fang ^d   Huang, Xiaoxia ^e   Chen, Zhenhua ^a   Fang, Yong ^a   Li, Bin ^a   Chen, Wei ^a   Xie, Dan ^e   Luo, Junhang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; FIBRONECTIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PROTEIN KINASE B; PROTEIN RAB25; RAB PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RAB GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84885142254     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt187     Document Type: Article

References (40)

1. Jemal, A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277-300.
2. Pelucchi, C. et al. (2006) Mechanisms of disease: The epidemiology of bladder cancer. Nat. Clin. Pract. Urol., 3, 327-340.
3. Parekh, D.J. et al. (2006) Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J. Clin. Oncol., 24, 5519-5527.
4. Kim, W.J. et al. (2008) Molecular biomarkers in urothelial bladder cancer. Cancer Sci., 99, 646-652.
5. Schwartz, S.L. et al. (2007) Rab GTPases at a glance. J. Cell Sci., 120(Pt 22), 3905-3910.
6. Goldenring, J.R. et al. (1993) Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung. J. Biol. Chem., 268, 18419-18422.
7. Lapierre, L.A. et al. (2001) Myosin vb is associated with plasma membrane recycling systems. Mol. Biol. Cell, 12, 1843-1857.
8. Agarwal, R. et al. (2009) The emerging role of the RAB25 small GTPase in cancer. Traffic, 10, 1561-1568.
9. Cheng, K.W. et al. (2005) Emerging role of RAB GTPases in cancer and human disease. Cancer Res., 65, 2516-2519.
10. Cheng, K.W. et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med., 10, 1251-1256.
11. Caswell, P.T. et al. (2007) Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell, 13, 496-510.
12. Dozynkiewicz, M.A. et al. (2012) Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev. Cell, 22, 131-145.
13. Yin, Y.X. et al. (2012) Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumour Biol., 33, 1581-1587.
14. Cheng, J.M. et al. (2006) Loss of RAB25 expression in breast cancer. Int. J. Cancer, 118, 2957-2964.
15. Nam, K.T. et al. (2010) Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J. Clin. Invest., 120, 840-849.
16. Goldenring, J.R. et al. (2011) Rab25 as a tumour suppressor in colon carcinogenesis. Br. J. Cancer, 104, 33-36.
17. Tong, M. et al. (2012) Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res., 72, 6024-6035.
18. Zheng, F. et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut, 61, 278-289.
19. Remmele, W. et al. (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe, 8, 138-140.
20. Saussez, S. et al. (2006) Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann. Surg. Oncol., 13, 999-1009.
21. Camp, R.L. et al. (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res., 10, 7252-7259.
22. Larue, L. et al. (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene, 24, 7443-7454.
23. Altomare, D.A. et al. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene, 24, 7455-7464.
24. Bakin, A.V. et al. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem., 275, 36803-36810.
25. Grille, S.J. et al. (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res., 63, 2172-2178.
26. Wen, W. et al. (2012) Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology, 55, 1787-1798.
27. Chen, R. et al. (2012) BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3β signaling pathway. Cancer Res., 72, 1579-1587.
28. Yan, D. et al. (2012) Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3-and MTA1/Wnt1 protein-dependent pathways. J. Biol. Chem., 287, 8598-8612.
29. Li, Z. et al. (2012) Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann. Oncol., 23, 638-646.
30. Kong, Q.L. et al. (2010) Epstein-Barr virus-encoded LMP2A induces an epithelial- mesenchymal transition and increases the number of side population stemlike cancer cells in nasopharyngeal carcinoma. PLoS Pathog., 6, e1000940.
31. Song, L.B. et al. (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest., 119, 3626-3636.
32. Maseki, S. et al. (2012) Acquisition of EMT phenotype in the gefitinibresistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway. Br. J. Cancer, 106, 1196-1204.
33. Polyak, K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
34. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
35. Kang, Y. et al. (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell, 118, 277-279.
36. Xue, Y. et al. (2011) Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction. PLoS One, 6, e27748.
37. Bruyere, F. et al. (2010) Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urol. Oncol., 28, 591-596.
38. Celià-Terrassa, T. et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest., 122, 1849-1868.
39. Julien, S. et al. (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene, 26, 7445-7456.
40. McConkey, D.J. et al. (2009) Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev., 28, 335-344.